MVA expressing modified HIV envelope, gag, and pol genes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8916172
SERIAL NO

12987791

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES6011 EXECUTIVE BOULEVARD SUITE 325 MSC 7660 BETHESDA MD 20892-7660

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Earl, Patricia Chevy Chase, US 9 47
Moss, Bernard Bethesda, US 51 625
Robinson, Harriet L Atlanta, US 19 261
Wyatt, Linda Rockville, US 8 73

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 23, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00